Targeting telomerase for cancer therapeutics

J. W. Shay, W. N. Keith

Research output: Contribution to journalShort surveypeer-review

140 Scopus citations


One of the hallmarks of advanced malignancies is continuous cell growth and this almost universally correlates with the reactivation of telomerase. Although there is still much we do not understand about the regulation of telomerase, it remains a very attractive and novel target for cancer therapeutics. Several clinical trials have been initiated, and in this review we highlight some of the most promising approaches and conclude by speculating on the role of telomerase in cancer stem cells.

Original languageEnglish (US)
Pages (from-to)677-683
Number of pages7
JournalBritish journal of cancer
Issue number4
StatePublished - Feb 26 2008


  • Ageing
  • Targeted therapeutics
  • Telomeres

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'Targeting telomerase for cancer therapeutics'. Together they form a unique fingerprint.

Cite this